Navigation Links
Key to acute lung injury lies in Ang2 protein

Acute lung injury caused by cell death, high and potentially toxic concentrations of oxygen (hyperoxia), and the resulting excess fluid in the lungs (pulmonary edema), may be controlled by modulating levels of the angiopoietin2 (Ang2) protein, researchers at Yale School of Medicine report in the November 5 online issue of Nature Medicine.

The study, which was completed in the laboratory of senior author Jack Elias, M.D., the Waldemar Von Zedtwitz Professor and chair of internal medicine at Yale, looked at the response to hyperoxic acute lung injury (HALI), first in mice and then in human adults and babies. The team found that mice in which the Ang2 gene was genetically eliminated or silenced lived longer and had evidence of decreased lung injury compared to mice in which the gene and protein were intact.

Levels of the Ang2 protein were then measured in the blood and lung fluid of adult patients and babies with acute lung damage and pulmonary edema. The team found that levels of Ang2, which is known to increase leaks in blood vessels and causes the death of endothelial cells that line the blood vessels, were higher in adult patients with acute lung injury and in babies born with respiratory distress syndrome who either went on to develop bronchopulmonary dysplasia or died.

"Mice without Ang2 seemed to be protected against hyperoxia," said first author Vineet Bhandari, M.D., assistant professor of pediatrics at Yale School of Medicine. "This protein seems to be a mediator of cell death in the settings of high oxygen concentrations in the lung causing acute lung injury and pulmonary edema."

Bhandari said the study is an example of true bench-to-bedside translational research. "All the work was initially done on mice in which we found that the Ang2 protein was involved in HALI," said Bhandari. "We also defined how the protein creates lung injury and then we showed its clinical relevance by documenting its presence in human patients w ith acute lung injury."

In addition to acute lung injury and pulmonary edema, Bhandari said, an increase in Ang2 and cell death can be seen in other disorders such as heart attacks, stroke, eye disease in diabetics and brain tumors.
'"/>

Source:Yale University


Related biology news :

1. Stem cells bring fast direct improvement, without differentiation, in acute renal failure
2. UNC launches study of liver injury caused by drugs
3. Brain-injury rehabilitation depends on acetylcholine circuitry
4. Stem cell treatment improves mobility after spinal cord injury
5. Combination therapy leads to partial recovery from spinal cord injury in rats
6. Study reveals genomics of inflammation from severe injury
7. Clinical trial to test stem cell approach for children with brain injury
8. Pittsburgh researchers discover that certain chemicals in the blood may indicate brain injury
9. Mayo Clinic collaboration discovers protein amplifies DNA injury signals
10. Cincinnati surgeons report new treatment for often-fatal injury
11. Spinal cord bridge bypasses injury to restore mobility

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... , Mar. 23, 2017 Research and ... System Market Analysis & Trends - Industry Forecast to 2025" ... ... grow at a CAGR of around 8.8% over the next decade ... industry report analyzes the market estimates and forecasts for all the ...
(Date:3/20/2017)... 2017 At this year,s CeBIT Chancellor Dr. ... DERMALOG. The Chancellor came to the DERMALOG stand together with the Japanese ... CeBIT partner country. At the largest German biometrics company the two government ... and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/9/2017)... March 9, 2017 4Dx has publicly released ... Imaging Workshop at the University of Pennsylvania. Founder and ... deliver the latest data to world leaders in lung ... together leaders at the forefront of the industry to ... "The quality of the imaging is ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... ... April 20, 2017 , ... USDM Life Sciences , the leading risk ... industries, is pleased to announce Holger Braemer as Vice President of its ... based in Germany. , Braemer is an integral part of USDM’s expansion of ...
(Date:4/20/2017)... ... 2017 , ... Parallel6™ , the leader in mClinical™ technologies for improving ... named one of the 2017 Top 10 eClinical Trial Management Solution Providers by ... , “We take pride in honoring Parallel6 as one of the top 10 companies ...
(Date:4/19/2017)... ... ... The Vibrating Orifice Aerosol Generator (VOAG) was developed in ... known diameters for research applications such as for calibrating droplet measuring instruments, for ... , The VOAG requires forcing liquid out of an orifice about half ...
(Date:4/19/2017)... ... April 19, 2017 , ... ... A-1 financing round. This event adds to several other early achievements at ThermaGenix, ... and Scientific Teams. , ThermaGenix will use proceeds from the Series ...
Breaking Biology Technology: